The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation
about
Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cellsAn alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpainMolecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2Heme oxygenase-1 modulates the expression of the anti-angiogenic chemokine CXCL-10 in renal tubular epithelial cellsChemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytesDifferential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cellsInterferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptorCXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis.The response of VEGF-stimulated endothelial cells to angiostatic molecules is substrate-dependent.Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous ScarringThe multifaceted functions of CXCL10 in cardiovascular diseaseCell surface heparan sulfate participates in CXCL1-induced signalingThe T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxisPathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases.Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages.Enhanced progenitor cell recruitment and endothelial repair after selective endothelial injury of the mouse kidney.Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain.Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5.Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications.Tumour vascularization: sprouting angiogenesis and beyondCXCL10 can inhibit endothelial cell proliferation independently of CXCR3.Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarringCXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stressesCXCR3 modulates obesity-induced visceral adipose inflammation and systemic insulin resistance.Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.Heparanase enhances myeloma progression via CXCL10 downregulation.The role of CXC chemokines in the regulation of tumor angiogenesis.Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction.Analysing the eosinophil cationic protein--a clue to the function of the eosinophil granulocyte.Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer.Chinese herbal medicine for miscarriage affects decidual micro-environment and fetal growth.Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment.Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10.Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapyEndothelial cell integrin laminin receptor expression in multiple sclerosis lesions.
P2860
Q24291028-D525E33B-B966-4541-A3B2-70FAA6ED53ACQ24303828-36AAD833-25BA-471B-90E5-924C90E16108Q24305068-1890E387-B710-48DC-91C3-EB953402D98EQ24321318-A47C983A-9359-4892-A37A-866EE2349E12Q24322029-925845E1-D9D1-4A8A-8769-E770EE96B472Q24336187-F9E0C01F-B590-4BA5-9571-19C0221DCF12Q24563090-A246FFBE-26FD-4A67-91A0-9FA789AEE6ABQ24647146-0B28D21B-8ABD-40FD-A9BC-C61E4606163BQ24683742-8BEF1BD4-829A-479F-8C47-4CAB1F901127Q24803773-5BF29228-FC85-49F6-80A3-7D4A59DA12CDQ24811681-C8E27D72-4164-45A0-B3EF-7E6419299B1EQ26778684-2CDD5854-53EC-4A0E-B2F2-DC385E6016FFQ27010051-B0C098C7-C8A2-44F3-A0D6-16DD51FDA667Q28205223-CF0E9D42-AA08-40A7-B92C-406BDCAFE7ABQ28239606-43039D27-C4B0-491F-9679-6168081AE7C2Q28259171-6D01A115-7DAF-4364-9345-665457D59C77Q28349180-69E34505-14C8-4D2F-BBB5-628E61A8AB15Q30332571-8A26329F-07C4-4AED-BF0B-39EC5FE49A83Q30428793-510AAFC7-2FB3-4985-8484-4C45553A14D5Q30433527-50C6BABA-6376-4D66-A555-D4A32667604EQ30494903-2987BEAD-C58B-4760-96BA-261862DBD0E5Q30856401-BC916033-82D6-4A5E-8041-B2193FD65E42Q30874393-BAEE918A-52EE-4BD8-A197-989D8259C2C9Q33375217-70A10776-3959-4DAC-B664-0204BBB4D55DQ33556162-F2A6EFE4-539E-4BD5-923A-4DD18F9344BCQ33698057-F6BDA2D3-3075-4D09-B857-C951015BB8FCQ33745172-4185C31F-6B73-448E-BC80-A51BCBE32B4FQ34096557-3AE54273-F609-46A8-87D1-6CB2B46703CCQ34206173-5BDFD251-7D23-4CAE-97FA-B68B7FF1E67AQ34231598-FC3C5280-4BDC-4450-B4FC-1E20330B45A4Q34289445-BDFED935-4ECB-4C84-8365-C00BDDCBD976Q34385436-23501638-2322-4351-A673-FFE682B40695Q34391833-48FB9A9F-1E1C-4271-A0AA-BF2BA5B321A7Q34537757-23036592-22AD-4909-87C6-C849D478ACDBQ34769124-EEF52602-66CD-4E04-A832-B06E597B16EDQ35395913-D43BD873-3B68-43B5-83ED-54B3EEF1FE10Q35507024-90CD12B4-C9A9-453E-B7CE-E9EEC6D6C2A7Q35648177-D52992C4-130B-429B-B4FE-8ED8B442CE5DQ35748830-E2975F26-6BDC-489A-80AB-1410D4285401Q35753240-297017FC-08D0-41AF-9B9B-07F847C65363
P2860
The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
The IP-10 chemokine binds to a ...... endothelial cell proliferation
@ast
The IP-10 chemokine binds to a ...... endothelial cell proliferation
@en
type
label
The IP-10 chemokine binds to a ...... endothelial cell proliferation
@ast
The IP-10 chemokine binds to a ...... endothelial cell proliferation
@en
prefLabel
The IP-10 chemokine binds to a ...... endothelial cell proliferation
@ast
The IP-10 chemokine binds to a ...... endothelial cell proliferation
@en
P2093
P2860
P356
P1476
The IP-10 chemokine binds to a ...... endothelial cell proliferation
@en
P2093
P2860
P304
P356
10.1084/JEM.182.1.219
P407
P577
1995-07-01T00:00:00Z